Difference between revisions of "Team:Tongji China"
Tongji2018 (Talk | contribs) |
Tongji2018 (Talk | contribs) |
||
| Line 25: | Line 25: | ||
<img src="https://static.igem.org/mediawiki/2018/3/3b/T--Tongji_China--picture-Home_page-2.png" width="50%;" style="float: right;" \> | <img src="https://static.igem.org/mediawiki/2018/3/3b/T--Tongji_China--picture-Home_page-2.png" width="50%;" style="float: right;" \> | ||
| − | <div class="HomepageContent">We focus our attention | + | <div class="HomepageContent">We focus our attention on |
| − | <br> | + | <br>cancer therapy and T3SS to |
| − | + | <br>create a new method to | |
| − | <br>new method to | + | <br>present the promising individual |
| − | <br>the promising individual | + | <br>cancer antigen -“Neoantigen”.<br></div> |
| − | <br>cancer antigen -“Neoantigen”<br></div> | + | |
</div> | </div> | ||
<div style="height: auto;margin-bottom: 20%;"> | <div style="height: auto;margin-bottom: 20%;"> | ||
<img src="https://static.igem.org/mediawiki/2018/2/25/T--Tongji_China--picture-Home_page-3.png" width="50%;" style="float: left;" \> | <img src="https://static.igem.org/mediawiki/2018/2/25/T--Tongji_China--picture-Home_page-3.png" width="50%;" style="float: left;" \> | ||
| − | <div class="HomepageContent">We use the bioinformatic | + | <div class="HomepageContent">We use the bioinformatic method |
| − | <br> | + | <br>to filter our item antigens and |
| − | <br> | + | <br>use the T3SS in P.A. to present |
| − | + | <br>them to the T cells through | |
| − | <br> | + | <br>oral intake.<br></div> |
| − | <br> | + | |
</div> | </div> | ||
<div style="height: auto;margin-bottom: 20%;"> | <div style="height: auto;margin-bottom: 20%;"> | ||
<img src="https://static.igem.org/mediawiki/2018/1/1f/T--Tongji_China--picture-Home_page-4.png" width="50%;" style="float:right;" \> | <img src="https://static.igem.org/mediawiki/2018/1/1f/T--Tongji_China--picture-Home_page-4.png" width="50%;" style="float:right;" \> | ||
| − | <div class="HomepageContent">We filter the antigens of | + | <div class="HomepageContent">We filter the antigens of interest. |
| − | <br> | + | <br>Then we conduct various experiments |
| − | + | <br>to prove that our system can work | |
| − | <br>prove that our system can | + | <br>efficiently and safely.<br></div> |
| − | <br> | + | |
</div> | </div> | ||
<div style="height: auto;margin-bottom: 20%;"> | <div style="height: auto;margin-bottom: 20%;"> | ||
<img src="https://static.igem.org/mediawiki/2018/7/78/T--Tongji_China--picture-Home_page-5.png" width="47%;" style="float: left;" \> | <img src="https://static.igem.org/mediawiki/2018/7/78/T--Tongji_China--picture-Home_page-5.png" width="47%;" style="float: left;" \> | ||
| − | <div class="HomepageContent">To improve the Integrity and | + | <div class="HomepageContent">To improve the Integrity and feasibility |
| − | <br> | + | <br>of our project, we consult many |
| − | <br> | + | <br>people for their advices and make |
| − | + | <br>use of Wechat pushes and presentation | |
| − | <br>Wechat pushes and presentation | + | |
<br>to popularize our project idea.<br></div> | <br>to popularize our project idea.<br></div> | ||
</div> | </div> | ||
| Line 64: | Line 60: | ||
<img src="https://static.igem.org/mediawiki/2018/d/da/T--Tongji_China--picture-Home_page-6.png" width="50%;" style="float: right;" \> | <img src="https://static.igem.org/mediawiki/2018/d/da/T--Tongji_China--picture-Home_page-6.png" width="50%;" style="float: right;" \> | ||
| − | <div class="HomepageContent">Each member in Tongji_China | + | <div class="HomepageContent">Each member in Tongji_China makes |
| − | <br> | + | <br>a great effort to make our |
| − | <br> | + | <br>project better. And also we appreciate |
| − | + | <br>the collaboration with other iGEMers.<br><br><br><br><br></div> | |
| − | <br>collaboration with iGEMers | + | |
| − | + | ||
</div> | </div> | ||
</div> | </div> | ||
Revision as of 12:10, 15 October 2018
Welcome to
Tongji_China
Tongji_China
We focus our attention on
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
We use the bioinformatic method
to filter our item antigens and
use the T3SS in P.A. to present
them to the T cells through
oral intake.
to filter our item antigens and
use the T3SS in P.A. to present
them to the T cells through
oral intake.
We filter the antigens of interest.
Then we conduct various experiments
to prove that our system can work
efficiently and safely.
Then we conduct various experiments
to prove that our system can work
efficiently and safely.
To improve the Integrity and feasibility
of our project, we consult many
people for their advices and make
use of Wechat pushes and presentation
to popularize our project idea.
of our project, we consult many
people for their advices and make
use of Wechat pushes and presentation
to popularize our project idea.
Each member in Tongji_China makes
a great effort to make our
project better. And also we appreciate
the collaboration with other iGEMers.
a great effort to make our
project better. And also we appreciate
the collaboration with other iGEMers.